🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 20 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/10/2019 97,96 99,66 97,60 98,12 +0,87% 2,10% 518.400
21/10/2019 96,80 97,70 94,41 97,27 +1,56% 3,40% 559.800
18/10/2019 98,38 100,41 93,60 95,78 -1,10% 6,92% 1.032.300
17/10/2019 94,42 97,80 93,60 96,85 +3,31% 4,45% 1.502.700
16/10/2019 92,89 93,98 92,42 93,75 +0,28% 1,68% 430.700
15/10/2019 91,43 94,30 91,42 93,49 +2,83% 3,15% 453.600
14/10/2019 90,15 92,28 89,50 90,92 +0,65% 3,08% 439.100
11/10/2019 88,95 91,93 88,83 90,33 +2,00% 3,49% 517.700
10/10/2019 86,72 88,67 86,14 88,56 +1,99% 2,92% 518.500
09/10/2019 87,30 88,05 86,43 86,83 +0,03% 1,86% 319.600
08/10/2019 86,88 88,26 84,68 86,80 -1,12% 4,12% 596.500
07/10/2019 89,73 90,17 87,24 87,78 -2,17% 3,27% 581.800
04/10/2019 90,52 91,75 89,13 89,73 -0,22% 2,89% 431.000
03/10/2019 88,55 90,82 88,00 89,93 +2,46% 3,18% 518.700
02/10/2019 88,56 89,24 86,00 87,77 -1,64% 3,66% 524.100
01/10/2019 90,47 92,49 88,87 89,23 -0,98% 4,00% 674.700
30/09/2019 90,70 91,08 88,95 90,11 -0,08% 2,35% 754.100
27/09/2019 90,66 92,50 88,63 90,18 -0,13% 4,27% 840.000
26/09/2019 95,71 96,77 90,09 90,30 -5,75% 6,98% 891.200
25/09/2019 96,69 97,15 94,74 95,81 -0,78% 2,49% 867.400
24/09/2019 100,80 101,74 96,38 96,56 -3,52% 5,32% 641.100
23/09/2019 100,80 101,94 100,01 100,08 -0,74% 1,91% 725.600
20/09/2019 102,08 102,51 100,49 100,83 -0,66% 1,98% 799.800
19/09/2019 101,27 102,36 100,89 101,50 +0,38% 1,45% 574.100
18/09/2019 101,49 102,23 100,35 101,12 -0,29% 1,85% 777.000
17/09/2019 98,25 101,80 98,06 101,41 +3,69% 3,81% 869.100
16/09/2019 95,83 99,90 95,83 97,80 +1,44% 4,25% 520.200
13/09/2019 93,59 97,64 93,39 96,41 +2,42% 4,54% 853.400
12/09/2019 95,73 96,19 92,90 94,13 -1,34% 3,44% 566.200
11/09/2019 95,21 97,72 94,19 95,41 +0,24% 3,71% 508.500